| http://www.w3.org/ns/prov#value | - RAS Mutation Detection in TumorsIndication: To detect activating point mutations in the KRAS and NRAS genes, which are commonly present in leukemias with monocytic differentiation (AML, CMML), and in solid tumors such as melanoma, lung cancer and colorectal carcinoma.
|
